2025 annual financial data
Edgewise Therapeutics 2025 Operating margin
Direct answer
Operating margin was Not calculable.
Operating income was -191,406,000 USD and net income was -167,795,000 USD.
Operating cash flow was -143,816,000 USD.
Get free Edgewise Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -191,406,000 USD
- Net income
- -167,795,000 USD
- Operating cash flow
- -143,816,000 USD